Literature DB >> 19788716

Urotensin II: a novel target in human corpus cavernosum.

Roberta d'Emmanuele di Villa Bianca1, Giuseppe Cirino, Emma Mitidieri, Ciro Coletta, Gianluca Grassia, Fiorentina Roviezzo, Paolo Grieco, Ettore Novellino, Ciro Imbimbo, Vincenzo Mirone, Raffaella Sorrentino.   

Abstract

INTRODUCTION: Urotensin II (U-II) is a cyclic peptide originally isolated from the teleost neurosecretory system and subsequently identified in other species, including man. U-II was identified as the natural ligand of an orphan G-protein coupled receptor (UT receptor). U-II and UT receptor are expressed in a variety of peripheral organs and especially in cardiovascular tissue. U-II caused both constrictor and vasodilator effect, depending by vascular bed. The in vivo functional consequences of U-II on the cardiovascular hemodynamics are not clearly understood. AIM: To investigate the presence of UT receptor and the effect of U-II in human corpus cavernosum (HCC) strips. To evaluate the effect of U-II in vivo in anesthetized rats.
METHODS: UT receptor expression as protein and as mRNA were assessed by Western blot and reverse transcriptase polymerase chain reaction. Next, the UT receptor localization was evaluated by immunohistochemical analysis. By using HCC strips, with or without endothelium, the effect of U-II (0.1 nM-10 microM) was evaluated. In order to asses the nitric oxide (NO) involvement, the strips were incubated with N (G)-nitro-L-arginine methyl ester (NO synthase inhibitor, 100 microM). U-II (0.1, 0.3, 1.0 nmol/rat) effect in vivo was studied in anesthetized rats by monitoring the intracavernous and systemic blood pressure. MAIN OUTCOME MEASURES: HCC expresses the UT receptor and its activation, by UII, causes an endothelium- and NO-dependent relaxation.
RESULTS: UT receptor is expressed in human and rat corpus cavernosum. In HCC UT receptor is localized on endothelial cells. U-II significantly relaxed HCC strips in endothelium- and -NO-dependent fashion. The peptide caused a significant increase in intracavernous pressure in anesthetized rats.
CONCLUSION: This study demonstrates that UT receptor is expressed on the endothelium of HCC. U-II/UT receptor system is involved in HCC function and it involves endothelium and NO pathway. Thus, U-II/UT receptor pathway could be involved in erectile function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19788716     DOI: 10.1111/j.1743-6109.2009.01450.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  4 in total

1.  Effects of urotensin II and its specific receptor antagonist urantide on rat vascular smooth muscle cells.

Authors:  Juan Zhao; Shu-Feng Zhang; Yan Shi; Li-Qun Ren
Journal:  Bosn J Basic Med Sci       Date:  2013-05       Impact factor: 3.363

2.  Endogenous urotensin II selectively modulates erectile function through eNOS.

Authors:  Roberta d'Emmanuele di Villa Bianca; Emma Mitidieri; Ferdinando Fusco; Elena D'Aiuto; Paolo Grieco; Ettore Novellino; Ciro Imbimbo; Vincenzo Mirone; Giuseppe Cirino; Raffaella Sorrentino
Journal:  PLoS One       Date:  2012-02-02       Impact factor: 3.240

3.  Human Cystathionine-β-Synthase Phosphorylation on Serine227 Modulates Hydrogen Sulfide Production in Human Urothelium.

Authors:  Roberta d'Emmanuele di Villa Bianca; Emma Mitidieri; Davide Esposito; Erminia Donnarumma; Erminia Donnarumm; Annapina Russo; Ferdinando Fusco; Angela Ianaro; Vincenzo Mirone; Giuseppe Cirino; Giulia Russo; Raffaella Sorrentino
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

4.  A new therapeutic approach to erectile dysfunction: urotensin-II receptor high affinity agonist ligands.

Authors:  Roberta d'Emmanuele di Villa Bianca; Emma Mitidieri; Erminia Donnarumma; Ferdinando Fusco; Nicola Longo; Giuseppe De Rosa; Ettore Novellino; Paolo Grieco; Vincenzo Mirone; Giuseppe Cirino; Raffaella Sorrentino
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.